FDA Issues Warning About Zoloft And Other SSRI Drugs
US Food and Drug Administration (FDA) advises medical doctors to continue their current clinical practice of treating depression in pregnant patients, they have issued warnings about the use of certain class of medications called selective serotonin-
While the US Food and Drug Administration (FDA) advises medical doctors to continue their current clinical practice of treating depression in pregnant patients, they have issued warnings about the use of certain class of medications called selective serotonin-reuptake inhibitors (SSRIs) such as Zoloft.
Scientific studies have been published which appears to show that infants born to women taking SSRIs like Zoloft may have a higher risk of birth defects.
On April 18, a new study was published in the journal PLoS ONE by the Public Library of Science which shows that Zoloft can have a devastating effect on yeast cells.
Ethan Perlstein, an associate research scholar at the Lewis-Sigler Institute for Integrative Genomics, and fellow researchers found that Zoloft triggers a protective response in yeast cells which degrades the cells and causing the cells to consume themselves.
This indicates that Zoloft might have more side effects than thought as Zoloft is designed to target serotonin transporters which yeast cells do not contain.“So these SSRIs were supposed to be safe, and yet we’re finding that these yeast are overdosing quite strongly in response to Zoloft,” said Perlstein.
More research is planned to confirm whether or not Zoloft might also destroy healthy human cells, including those in a developing fetus.
A 2006 study published by the New England Journal of Medicine showed that women who used Zoloft after the 20th week of pregnancy are six times more likely to give birth to an infant with persistent pulmonary hypertension of the newborn (PPHN). PPHN is a serious and potentially fatal circulatory situation
.In another study published in 2007 by the same source, New England Journal of Medicine, found that children born of women who used Zoloft during pregnancy were two times as likely to suffer heart related Zoloft birth defects.
The most common heart defects in the study were ventricular outflow defects and septal defects.Zoloft is prescribed to treat depression and certain disorders such as obsessive compulsive disorder.
The FDA recommends that women that are pregnant or planning to become pregnant should consult their medical professional about whether they should continue their current treatment if they are using SSRIs such as Zoloft.
D. Miller & Associates, PLLC, is a law firm based in Houston, Texas involved in many Zoloft birth defects lawsuits.
D. Miller & Associates, P.L.L.C.
10565 Katy Freeway, Suite 400
Houston, Texas 77024
- Contact Information
- Meo Pisha
- Media Relations
- D. Miller & Associates, PLLC
- (1) 1-855-776-5299
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.